July 27, 2026

BeOne Medicines Ltd. (ONC) Stock Analysis: A 27.54% Upside Potential with a Strong Buy Consensus

BeOne Medicines Ltd. (ONC) is capturing the attention of investors with its promising growth prospects and robust pipeline in the biotechnology sector. Headquartered in Basel, Switzerland, this oncology-focused company is..

Natera, Inc. (NTRA) Stock Analysis: Unpacking the 38.8% Revenue Growth and Investor Ratings

Natera, Inc. (NASDAQ: NTRA), headquartered in Austin, Texas, is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. The company is renowned for its cutting-edge..

Veeva Systems Inc. (VEEV) Investor Outlook: A Promising 31% Potential Upside in the Healthcare Sector

Veeva Systems Inc. (NYSE: VEEV) stands out in the healthcare sector, particularly within the health information services industry, where it has carved a niche as a pivotal provider of cloud-based..

Sanofi (SNY) Stock Analysis: Evaluating a 27% Upside Potential in Healthcare Giant

Sanofi (NASDAQ: SNY), a stalwart in the healthcare sector, continues to capture investor attention with its promising 27% potential upside. As a global leader in drug manufacturing, Sanofi is headquartered..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 30.96% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) presents an intriguing opportunity for investors with its strong position in the healthcare sector, particularly in the medical devices industry. Headquartered in Chicago, Illinois,..

CVS Health Corporation (CVS) Stock Analysis: Navigating Growth with a Forward P/E of 12.80

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, boasting a market capitalization of $137.47 billion. As a leader in healthcare plans within the United..

Cardinal Health (CAH) Stock Analysis: Navigating a 10.69% Potential Upside in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a heavyweight in the healthcare sector, is drawing attention from investors with its promising potential upside of 10.69%. As a key player in the medical..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a 16.25% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a titan in the biotechnology sector, continues to capture investor attention with its promising pipeline and robust market presence. As of the latest trading session,..

GSK plc (GSK) Stock Analysis: Evaluating a 13.10% Potential Upside in the Healthcare Giant

GSK plc (NYSE: GSK), a stalwart in the healthcare sector with a market capitalization of $102.84 billion, commands significant attention from investors worldwide. Known for its robust portfolio of vaccines,..

The Cigna Group (CI) Investor Outlook: Strong Buy Ratings and a 17.73% Potential Upside

Investors keeping an eye on the healthcare sector should take note of The Cigna Group (CI), a giant in the healthcare plans industry with a market cap of $76.6 billion...

Elevance Health, Inc. (ELV) Stock Analysis: Exploring an 18.91% Potential Upside

Elevance Health, Inc. (NYSE: ELV), previously known as Anthem, Inc., stands as a formidable player in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of..

Pfizer, Inc. (PFE)

⚠️ No article content returned.

..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating Growth Potential and Analyst Ratings

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to captivate investors with its robust market presence and substantial growth prospects. With a market capitalization of $634.77..

Stryker Corporation (SYK) Stock Analysis: Healthcare Giant with a 17% Potential Upside

For investors seeking a stable yet promising player in the healthcare sector, Stryker Corporation (NYSE: SYK) presents a compelling opportunity. As a leading entity in the medical devices industry, Stryker’s..

Gilead Sciences, Inc. (GILD) Stock Analysis: Unveiling a 21.81% Potential Upside for Investors

Investors eyeing Gilead Sciences, Inc. (NASDAQ: GILD) may find themselves intrigued by the stock’s current positioning within the healthcare sector, particularly the drug manufacturing industry. With a robust market capitalization..

Eli Lilly (LLY) Stock Analysis: Uncovering Growth Potential in the Healthcare Behemoth

Eli Lilly and Company (NYSE: LLY) stands as a formidable force in the healthcare sector, boasting a staggering market capitalization of $1.07 trillion. This pharmaceutical giant, headquartered in Indianapolis, Indiana,..

India’s smart meter rollout builds a larger grid technology market

India’s expanding smart meter network is creating demand for scalable connectivity, software and digital grid services...

Quadrise targets more value from heavy refinery residues

Quadrise MSAR® and bioMSAR™ offer a direct route to lower blending costs, greater residue flexibility and shared commercial value...

Cooks Coffee Company publishes latest ESG newsletter

Cooks Coffee Company Limited has published its latest ESG newsletter, updating shareholders on sustainability, responsible sourcing, community engagement and franchise development...

Vesuvius lowers 2026 profit outlook amid Steel division issues

Vesuvius Plc has issued a trading update for H1 2026, expecting trading profit of about £74m. The company said temporary operational issues in its Steel division and tough conditions in..
Search

Funds

July 27, 2026

India’s smart meter rollout builds a larger grid technology market

India’s expanding smart meter network is creating demand for scalable connectivity, software and digital grid services...

Quadrise targets more value from heavy refinery residues

Quadrise MSAR® and bioMSAR™ offer a direct route to lower blending costs, greater residue flexibility and shared commercial value...

Cooks Coffee Company publishes latest ESG newsletter

Cooks Coffee Company Limited has published its latest ESG newsletter, updating shareholders on sustainability, responsible sourcing, community engagement and franchise development...

Vesuvius lowers 2026 profit outlook amid Steel division issues

Vesuvius Plc has issued a trading update for H1 2026, expecting trading profit of about £74m. The company said temporary operational issues in its Steel division and tough conditions in Advanced Refractories, especially in Europe, are weighing on performance. Full-year trading profit is now expected to be slightly ahead of FY25 on a constant currency basis...
Search

Funds

July 27, 2026

FTSE 100

Funds